SNSS - Sunesis Pharmaceuticals EPS beats by $0.06 November, 16 2020 04:14 PM Viracta Therapeutics Inc Com Sunesis Pharmaceuticals (SNSS): Q3 GAAP EPS of -$0.29 beats by $0.06.Cash and equivalents totaled $26M.Shares -0.77%.Press Release For further details see: Sunesis Pharmaceuticals EPS beats by $0.06